on The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Position in Mural Oncology plc
The Vanguard Group, Inc. has submitted Form 8.3, disclosing its interests in Mural Oncology plc. Under the Irish Takeover Panel Act of 1997, such disclosures are mandatory for entities holding 1% or more in relevant securities.
As of May 23, 2025, Vanguard owns 4.48% of Mural Oncology's $0.01 ordinary shares, totaling 772,867 shares. No additional interests in cash-settled derivatives or stock-settled derivatives are reported.
Recent dealings include the sale of 18 ordinary shares at $2.75 each. No agreements or understandings affecting voting rights or future acquisitions are disclosed. The document states no indemnity arrangements exist.
Form 8.3 filings provide transparency in takeover situations, ensuring market integrity and accountability.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all The Vanguard Group, Inc. news